Most importantly, the quantity of Aurora-A in mammalian cells may serve as a crucial mediator of osteopontin/CD44-dependent biological events via the activation of ERK signaling pathway, resulting in the progression of HNSCC. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.